Ophthalmic billing is among the most technically demanding in medicine. The same visit can be billed as an E/M code or an eye exam code — and the choice costs or earns thousands per month. Retinal injections require 90-day global period tracking. Cataract surgery has a bundled global package. Diagnostic imaging (OCT, visual fields, fundus photography) each have specific medical necessity requirements. ParaMed's ophthalmology billing team knows every rule across every subspecialty — and bills every visit at its maximum legitimate reimbursement.
E/M codes (99202–99215) use the standard physician visit documentation framework — History, Exam, and Medical Decision Making or Total Time. They're appropriate when the visit is primarily medical, involves significant systemic management, or when MDM complexity supports a higher-level code than the eye exam equivalent.
Eye exam codes (92002–92014) are ophthalmology-specific codes that use ophthalmic documentation elements — General Medical Observation, anterior and posterior segment examination, and documented initiation or continuation of a treatment program. Most ophthalmic payers recognize these codes when documentation is ophthalmic-specific.
Ophthalmologists are among the only physicians who must actively choose between two parallel visit code systems for the same appointment. The correct choice depends on visit type, patient status, and clinical complexity. Most billing companies default to one system and leave revenue on the table. ParaMed selects the optimal code type for every single visit.
E/M codes use the standard medical documentation framework established in CMS's E/M guidelines: History (HPI, ROS, PFSH), Physical Examination, and Medical Decision Making — or, since 2021, total time-based billing. These codes are appropriate when the ophthalmologist is managing systemic conditions affecting the eye, when multiple problems require complex decision making, or when the visit involves significant non-ophthalmic management that supports higher MDM.
A diabetic patient with proliferative diabetic retinopathy requiring complex MDM — reviewing labs, adjusting referral plan, coordinating with endocrinology — supports 99215 ($196), which is $84 more than 92014 ($112). E/M wins when systemic management complexity is high.
Eye exam codes (92002–92014) are ophthalmology-specific visit codes that use ophthalmic examination elements instead of the standard E/M H/P/MDM framework. They require "General Medical Observation" (a brief systemic history) plus a comprehensive or intermediate ophthalmic examination covering anterior and posterior segment, and documentation of initiation or continuation of a treatment program.
A new patient with a new diagnosis of open-angle glaucoma initiating a new treatment program receives 92004 ($168) — higher than 99204 ($166) for comparable documentation. For straightforward new ophthalmic diagnoses, 92004 is the natural and more remunerative choice.
An ophthalmologist seeing 25 established diabetic patients per week who defaults to 92014 ($112) instead of the supportable 99215 ($196) is leaving $84 per visit × 25 visits × 52 weeks = $109,200 per year in legitimate unrealized revenue. The reverse also happens: billing 92004 when documentation only supports 92012 generates overpayment that triggers audit and recoupment. Both errors are systemic, recurring, and entirely preventable with specialty expertise.
ParaMed's ophthalmic billing team applies a 4-question decision protocol to every visit note: (1) Is the visit primarily medical or ophthalmic? (2) Does MDM complexity support an E/M level above the eye exam equivalent? (3) Is documentation written in E/M or ophthalmic examination language? (4) Is the patient new or established — and does new status change the selection? The answer to all four determines code selection on every single visit — no defaults to one system.
Each ophthalmology subspecialty has its own CPT codes, global period rules, modifiers, and payer-specific quirks that generic medical billers don't know. ParaMed bills every subspecialty with specialty-specific precision — not generic physician billing logic.
Complete ophthalmic revenue cycle management by AAPC-certified coders who specialize in ophthalmology — not general surgery billers who occasionally code an eye procedure. Every E/M decision, every global period, every intravitreal drug claim, every diagnostic imaging necessity review — handled by experts who live in ophthalmic billing every day.
Every ophthalmic visit reviewed against both E/M and Eye Exam code criteria. The visit type generating maximum legitimate reimbursement for the documented service is selected — not a default to one system.
Cataract surgery (090 days), laser procedures (010 or 090 days), MIGS, and retinal procedures all bundle post-op care. Incorrect post-op billing is the second-leading cause of ophthalmic audit triggers across all payers.
Retinal practices billing Eylea, Lucentis, Vabysmo, and biosimilar injections must correctly pair 67028 with the drug J-code, NDC number, units administered, and correct modifier. Missing any element denies the highest-value claims in ophthalmic billing.
OCT, visual fields, fundus photography, fluorescein angiography, and corneal topography are the most-denied ophthalmic services — because they require specific medical necessity documentation linking the imaging to a covered diagnosis and clinical indication.
Functional blepharoplasty and ptosis repair require specific pre-operative documentation that most billing teams never verify before surgery. Once surgery occurs, missing documentation cannot be retroactively created — the claim is permanently unsupportable.
The highest-value ophthalmic procedures — CXL, MIGS, vitreoretinal surgery, amniotic membrane — all require prior authorization. Performing any of these without confirmed PA means a $3,000–$8,000+ claim that pays $0, with no retroactive approval path.
Your practice generates revenue across general ophthalmology, retina injections, surgical cases, and diagnostics simultaneously. ParaMed tracks per-surgeon revenue, E/M vs Eye Exam code distribution, global period status per surgical patient, intravitreal drug billing accuracy, and payer-specific denial patterns — all in real time.
See Our DashboardE/M vs Eye Exam decision tracked per visit
Every J-code + NDC + unit verified pre-submit
Post-op visit status tracked per surgical patient
All denials actioned within 48hr with specific fix
Global periods are among the most misunderstood billing concepts in ophthalmology. Post-operative visits are bundled into the surgical fee for the global period duration — but exceptions exist for unrelated conditions, complications, and staged procedures. Incorrectly billing bundled services is the leading ophthalmic billing compliance risk and audit trigger. ParaMed tracks every surgical patient's global period status in real time.
If a patient develops an unrelated eye condition during the 90-day cataract global period — such as a new episode of uveitis unrelated to the surgery — bill the E/M with modifier -24. Document clearly that the visit is for the unrelated condition.
A complication requiring a return to the operating room during the global period is billed with modifier -78 (unplanned return to OR during post-op period). Modifier -78 reduces payment by the surgical component only.
When cataract surgery on the second eye is planned and performed during the global period of the first eye's cataract, use modifier -58 (staged procedure). This correctly identifies the second eye surgery as planned — not a complication — and pays the full surgical fee for the second eye.
If a second SLT is performed to the same eye within the 90-day global of the first, use modifier -76 (repeat procedure by same physician). Without -76, the second procedure is denied as a duplicate. Document clinical rationale for repeat treatment.
If the patient develops a new glaucoma-related problem beyond the expected SLT post-op course — such as a pressure spike requiring emergency management or new disc hemorrhage — bill the visit with -24 if the documentation clearly distinguishes the visit from routine post-laser monitoring.
SLT performed at the same surgical session as cataract surgery requires -51 modifier for the secondary procedure. If SLT is performed at a distinct time during the cataract global period, modifier -79 applies (unrelated procedure during post-op period).
A patient who receives an intravitreal injection (67028) during the 90-day global of a vitrectomy for a different indication bills the injection with modifier -79 (unrelated procedure during post-op period).
Visits for the contralateral eye are always separately billable even during the operative eye's global period. Use modifier -RT or -LT to distinguish. Do NOT use -24 for contralateral eye visits — -24 is for unrelated conditions to the same operative episode.
PPV is often performed with add-on procedures — membrane peel (67041/67042), laser endophotocoagulation, scleral buckle (67107). Document each component performed separately; bill add-on codes with -51 per correct bundling guidelines.
If a significant and separately identifiable evaluation is performed on the same day as an intravitreal injection — reviewing OCT findings, adjusting treatment protocol, or evaluating a new complaint — the E/M code is billable with modifier -25. The injection and exam must be documented as separate services.
When injections are performed in both eyes on the same day, bill 67028 twice — once with modifier -RT and once with -LT. Most payers do NOT recognize -50 for intravitreal injections; using -50 instead of RT/LT results in partial payment or denial at most retina payers.
Every intravitreal drug claim requires the National Drug Code (NDC) on the claim line. NDC must be in 11-digit format (5-4-2) with units and qualifier. Missing NDC generates automatic rejection — not denial — meaning the claim never reaches adjudication and must be corrected and resubmitted.
Ophthalmic billing denials are highly specific and highly recoverable — when you know what caused them. ParaMed's denial management program identifies every denial by root cause, applies the correct fix, and tracks recovery through payment — so no ophthalmic revenue stays permanently denied.
Every denial received via ERA/EOB categorized by denial reason code within 24 hours of adjudication. Root cause identified (medical necessity, modifier, global period, NDC, etc.).
Denial assessed: Is this fixable with a corrected claim? Does it require medical necessity documentation? Is it within timely filing window? Is it a payer error appealable?
Missing NDC added. Modifier applied. Medical necessity documentation requested from provider. Appeal letter drafted with supporting clinical documentation.
Corrected claim resubmitted electronically within 48 hours. First-level appeal filed with clinical documentation. Timely filing deadlines tracked per payer per claim.
Resubmitted claim tracked to adjudication. Payment posted and confirmed. Persistent denials escalated to peer-to-peer review or second-level appeal process.
Average annual revenue recovered from prior A/R for ophthalmology practices in their first year with ParaMed — from denied retinal injections, unbilled global period exceptions, missed bilateral modifiers, and uncorrected OCT medical necessity denials.
Every intravitreal drug claim (J0178 Eylea, J2778 Lucentis, J0172 Vabysmo) requires the National Drug Code in 11-digit format. Missing NDC generates an automatic rejection. For practices billing 40+ injections per month at $895+ per encounter, systematic NDC errors create $36,000+ in monthly rejection exposure.
Billing a 92014 or E/M visit during the 90-day global period of cataract surgery, SLT, or vitreoretinal surgery without the correct exception modifier (-24 for unrelated, -78 for complication, -79 for unrelated procedure) generates an automatic global period bundling denial. At $112–$196 per visit, routine post-op visits incorrectly billed outside the global generate systematic denial patterns that also trigger payer audits.
OCT (92134 macula, 92133 optic disc), visual fields (92083), and fundus photography (92250) each require documented medical necessity linking the imaging to a specific covered diagnosis and clinical indication. "Routine monitoring" is not sufficient — the note must state why imaging is clinically necessary for that specific patient on that specific date.
When a significant and separately identifiable E/M visit is performed on the same day as a minor ophthalmic procedure (injection, laser treatment, minor surgery), the E/M requires modifier -25 to be paid separately. Without -25, the payer assumes the E/M is bundled into the procedure payment and denies the visit code.
Many ophthalmic procedures and imaging services are performed bilaterally. Without the correct bilateral modifier, the payer reimburses for only one eye. The modifier requirement varies by code and payer — some use -50, others require separate RT and LT claims. Bilateral injection claims particularly require RT/LT rather than -50 at most retina payers.
From routine eye exams through complex vitreoretinal surgery — every ophthalmic procedure has specific coding requirements, global period rules, and payer-specific coverage policies. ParaMed handles the complete billing lifecycle for every service your practice provides.
The revenue foundation of general ophthalmology — 92002/92004/92012/92014 eye exam codes and 99202–99215 E/M codes — optimized per visit for maximum reimbursement.
The highest-volume ophthalmic surgery — global period management, IOL selection documentation, astigmatism correction modifiers, and bilateral staging are all managed per case.
High-frequency, high-value retinal injections — Eylea, Lucentis, Vabysmo, Avastin — billed with correct J-codes, NDC numbers, and bilateral modifier per payer requirements.
SLT (65855), trabeculectomy (66170), and MIGS procedures billed with correct global period tracking, MIGS-cataract combination coding, and payer-specific bundling rule awareness.
OCT, visual fields, fundus photography, fluorescein angiography, and corneal topography — all billed with verified medical necessity documentation and correct bilateral modifier application.
Functional blepharoplasty (15823) and ptosis repair (67900) billed with pre-operative VF documentation, clinical photography confirmation, and MRD1 measurement review for every claim.
How every ophthalmic encounter moves from patient visit through final payment at ParaMed
Medicare, Medicare Advantage, commercial insurers, and Medicaid all have different rules for ophthalmic billing. ParaMed maintains current ophthalmic billing rules for every major payer type.
Traditional Medicare is the dominant payer for most ophthalmology practices — and the most regulated. CMS publishes Local Coverage Determinations (LCDs) for ophthalmic diagnostics and procedures that specify exact medical necessity requirements, diagnosis code requirements, and documentation standards. Non-compliance with LCD criteria generates automatic denials that are difficult to overturn on appeal.
Medicare Advantage plans add a significant layer of complexity beyond traditional Medicare — each MA plan maintains its own prior authorization requirements, formulary restrictions for intravitreal drugs, and ophthalmic benefit structures that can differ dramatically from traditional Medicare. A practice managing 200+ MA patients has potentially dozens of different PA requirements and formularies to track simultaneously.
Commercial insurers add a layer of ophthalmic billing complexity that Medicare doesn't have — often separating "medical" eye benefits (for ophthalmologists treating disease) from "vision" benefits (for optometrists providing routine exams and glasses). An ophthalmologist treating a patient for diabetic retinopathy bills medical insurance, while the same patient's routine refraction is a vision benefit.
Medicaid ophthalmic coverage is state-specific and often limited — but where covered, it must be billed with precision. Managed Medicaid MCO plans add authorization requirements on top of base Medicaid coverage. Adult Medicaid ophthalmic coverage is particularly variable — some states cover emergency ophthalmic care only, while others cover comprehensive ophthalmology including surgery for documented conditions.
Each patient visit assessed against both code frameworks — maximum legitimate reimbursement selected per documentation. No defaults to one system.
Every intravitreal drug claim submitted with verified NDC, units administered, and route of administration. Zero NDC rejection rate.
Every surgical patient's global period tracked in real time. Post-op visits assessed for billing eligibility before submission — no bundling denials.
OCT, VF, and imaging claims reviewed for diagnosis-linked necessity documentation before submission. Zero generic "routine monitoring" denials.
Pre-op VF, photo, and MRD1 documentation verified before every functional blepharoplasty and ptosis repair claim — audit-proof documentation.
Per-surgeon E/M vs Eye Exam distribution, injection billing accuracy, global period exceptions, payer-specific denial patterns — monthly detail.
We're a retina practice — 4 surgeons, 600+ injections per month. Our previous biller had no idea what NDC meant. We were getting systematic rejections on our Eylea and Vabysmo claims, and our post-op billing was a disaster — we had cataract surgeries billed with no global period tracking whatsoever. ParaMed fixed both issues in the first month. They recovered $178,000 from our prior A/R in 90 days and our monthly collection rate went from 64% to 96%. The NDC rejections are gone. The post-op violations are gone. I only wish we had found them years ago.
The questions every general ophthalmologist, retina specialist, glaucoma specialist, and oculoplastic surgeon asks before trusting an outside billing company with ophthalmic revenue — answered with the technical depth eye care professionals expect.
We'll analyze 3 months of ophthalmic claims — E/M vs Eye Exam optimization, global period compliance, intravitreal drug billing accuracy, diagnostic imaging necessity, and bilateral modifier application — and show you exactly how much revenue your practice is leaving uncollected.
Trusted by Practices Across US — Feedback from providers who rely on ParaMed for smarter Medical Billing.
